Liu X - Search Results

1

MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma.

Xu Q, Zhang M, Tu J, Pang L, Cai W, Liu X. Xu Q, et al. Among authors: liu x. Oncol Rep. 2015 Oct;34(4):2054-64. doi: 10.3892/or.2015.4175. Epub 2015 Aug 5. Oncol Rep. 2015. Retraction in: Oncol Rep. 2023 Feb;49(2):38. doi: 10.3892/or.2023.8475 PMID: 26252254 Retracted.

2

PKM2 regulates Gli1 expression in hepatocellular carcinoma.

Xu Q, Liu X, Zheng X, Yao Y, Liu Q. Xu Q, et al. Among authors: liu x, liu q. Oncol Lett. 2014 Nov;8(5):1973-1979. doi: 10.3892/ol.2014.2441. Epub 2014 Aug 12. Oncol Lett. 2014. PMID: 25289083 Free PMC article.

3

HSP90 inhibits apoptosis and promotes growth by regulating HIF-1α abundance in hepatocellular carcinoma.

Liu X, Chen S, Tu J, Cai W, Xu Q. Liu X, et al. Int J Mol Med. 2016 Mar;37(3):825-35. doi: 10.3892/ijmm.2016.2482. Epub 2016 Feb 5. Int J Mol Med. 2016. PMID: 26846697

4

[The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].

Xu Q, Cai W, Zhang M, Liu Q, Liu X. Xu Q, et al. Among authors: liu x, liu q. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Mar;32(3):387-92. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016. PMID: 26927562 Chinese.

5

MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.

Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K. Xu Q, et al. Among authors: liu z, liu x. Mol Cancer. 2017 Jun 12;16(1):103. doi: 10.1186/s12943-017-0675-y. Mol Cancer. 2017. PMID: 28606154 Free PMC article.

6

microRNA-526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma.

Liu X, Yang L, Tu J, Cai W, Zhang M, Shou Z, Yao Y, Xu Q. Liu X, et al. Oncotarget. 2017 Sep 23;8(50):87737-87749. doi: 10.18632/oncotarget.21209. eCollection 2017 Oct 20. Oncotarget. 2017. PMID: 29152116 Free PMC article.

7

HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.

Xu Q, Tu J, Dou C, Zhang J, Yang L, Liu X, Lei K, Liu Z, Wang Y, Li L, Bao H, Wang J, Tu K. Xu Q, et al. Among authors: liu z, liu x. Mol Cancer. 2017 Dec 20;16(1):178. doi: 10.1186/s12943-017-0748-y. Mol Cancer. 2017. PMID: 29262861 Free PMC article.

8

[Corrigendum] MicroRNA‑122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma.

Xu Q, Zhang M, Tu J, Pang L, Cai W, Liu X. Xu Q, et al. Among authors: liu x. Oncol Rep. 2021 Jul;46(1):122. doi: 10.3892/or.2021.8073. Epub 2021 May 13. Oncol Rep. 2021. PMID: 33982780 Free PMC article.

9

MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1.

Xu Q, Zhu Q, Zhou Z, Wang Y, Liu X, Yin G, Tong X, Tu K. Xu Q, et al. Among authors: liu x. Biomed Pharmacother. 2018 Jul;103:645-652. doi: 10.1016/j.biopha.2018.04.037. Epub 2018 Apr 24. Biomed Pharmacother. 2018. PMID: 29679906

10

Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis.

Xu Q, Dou C, Liu X, Yang L, Ni C, Wang J, Guo Y, Yang W, Tong X, Huang D. Xu Q, et al. Among authors: liu x. Biomed Pharmacother. 2018 Nov;107:1692-1704. doi: 10.1016/j.biopha.2018.07.071. Epub 2018 Sep 8. Biomed Pharmacother. 2018. PMID: 30257387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136,749 results

Search Page

Filters